PBRM1 and nonpapillary renal cell carcinoma: Understanding the molecular mechanisms underlying ccRCC is enhanced by the occurrence of missense mutations and the discovery of commonly mutated genes like VHL and PBRM1.These findings also raise the possibility of developing targeted therapeutic strategies based on specific genetic alterations.